Ameriprise’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $821M | Sell |
1,670,400
-14,545
| -0.9% | -$7.89M | 0.19% | 117 |
|
|
2025
Q4 | $977M | Buy |
1,684,945
+111,947
| +7% | +$63.3M | 0.22% | 94 |
|
|
2025
Q3 | $763M | Sell |
1,572,998
-115,887
| -7% | -$53.9M | 0.18% | 117 |
|
|
2025
Q2 | $685M | Sell |
1,688,885
-387,749
| -19% | -$162M | 0.17% | 125 |
|
|
2025
Q1 | $1.03B | Sell |
2,076,634
-154,396
| -7% | -$83.6M | 0.28% | 73 |
|
|
2024
Q4 | $1.16B | Sell |
2,231,030
-249,621
| -10% | -$137M | 0.3% | 64 |
|
|
2024
Q3 | $1.53B | Sell |
2,480,651
-606
| -0% | -$359K | 0.39% | 43 |
|
|
2024
Q2 | $1.37B | Buy |
2,481,257
+604,895
| +32% | +$347M | 0.37% | 43 |
|
|
2024
Q1 | $1.09B | Buy |
1,876,362
+493,302
| +36% | +$277M | 0.3% | 65 |
|
|
2023
Q4 | $734M | Sell |
1,383,060
-96,553
| -7% | -$46.7M | 0.22% | 96 |
|
|
2023
Q3 | $749M | Sell |
1,479,613
-110,418
| -7% | -$58.8M | 0.25% | 85 |
|
|
2023
Q2 | $830M | Sell |
1,590,031
-35,771
| -2% | -$19.3M | 0.26% | 84 |
|
|
2023
Q1 | $937M | Sell |
1,625,802
-40,104
| -2% | -$22.6M | 0.31% | 72 |
|
|
2022
Q4 | $917M | Buy |
1,665,906
+70,251
| +4% | +$37.2M | 0.31% | 75 |
|
|
2022
Q3 | $817M | Sell |
1,595,655
-329,549
| -17% | -$184M | 0.3% | 76 |
|
|
2022
Q2 | $1.04B | Buy |
1,925,204
+448,143
| +30% | +$247M | 0.36% | 59 |
|
|
2022
Q1 | $846M | Sell |
1,477,061
-24,603
| -2% | -$14.1M | 0.25% | 81 |
|
|
2021
Q4 | $967M | Buy |
1,501,664
+534,801
| +55% | +$334M | 0.27% | 75 |
|
|
2021
Q3 | $552M | Sell |
966,863
-458,589
| -32% | -$252M | 0.18% | 118 |
|
|
2021
Q2 | $719M | Sell |
1,425,452
-15,768
| -1% | -$7.44M | 0.22% | 95 |
|
|
2021
Q1 | $658M | Sell |
1,441,220
-138,539
| -9% | -$66.1M | 0.22% | 95 |
|
|
2020
Q4 | $736M | Buy |
1,579,759
+446,694
| +39% | +$209M | 0.26% | 78 |
|
|
2020
Q3 | $500M | Sell |
1,133,065
-11,544
| -1% | -$4.77M | 0.2% | 103 |
|
|
2020
Q2 | $415M | Sell |
1,144,609
-98,441
| -8% | -$33M | 0.18% | 121 |
|
|
2020
Q1 | $352M | Buy |
1,243,050
+20,878
| +2% | +$6.58M | 0.18% | 120 |
|
|
2019
Q4 | $397M | Buy |
1,222,172
+23,554
| +2% | +$7.14M | 0.17% | 133 |
|
|
2019
Q3 | $349M | Sell |
1,198,618
-292,978
| -20% | -$83.9M | 0.16% | 135 |
|
|
2019
Q2 | $438M | Buy |
1,491,596
+17,363
| +1% | +$4.78M | 0.2% | 105 |
|
|
2019
Q1 | $403M | Sell |
1,474,233
-37,085
| -2% | -$9.23M | 0.19% | 111 |
|
|
2018
Q4 | $338M | Sell |
1,511,318
-60,012
| -4% | -$14.1M | 0.17% | 123 |
|
|
2018
Q3 | $494M | Buy |
1,571,330
+353,964
| +29% | +$81.4M | 0.17% | 124 |
|
|
2018
Q2 | $252M | Sell |
1,217,366
-32,431
| -3% | -$6.88M | 0.11% | 192 |
|
|
2018
Q1 | $258M | Sell |
1,249,797
-225,041
| -15% | -$47.2M | 0.12% | 192 |
|
|
2017
Q4 | $280M | Sell |
1,474,838
-1,070,524
| -42% | -$205M | 0.13% | 171 |
|
|
2017
Q3 | $482M | Buy |
2,545,362
+90,393
| +4% | +$16.4M | 0.23% | 98 |
|
|
2017
Q2 | $428M | Sell |
2,454,969
-258,185
| -10% | -$43.4M | 0.21% | 107 |
|
|
2017
Q1 | $417M | Sell |
2,713,154
-61,436
| -2% | -$9.39M | 0.22% | 102 |
|
|
2016
Q4 | $392M | Buy |
2,774,590
+170,393
| +7% | +$25.1M | 0.21% | 102 |
|
|
2016
Q3 | $414M | Sell |
2,604,197
-103,471
| -4% | -$15.9M | 0.23% | 92 |
|
|
2016
Q2 | $400M | Sell |
2,707,668
-464,338
| -15% | -$68.5M | 0.23% | 92 |
|
|
2016
Q1 | $449M | Buy |
3,172,006
+229,116
| +8% | +$30.7M | 0.27% | 77 |
|
|
2015
Q4 | $417M | Buy |
2,942,890
+267,564
| +10% | +$35.7M | 0.25% | 90 |
|
|
2015
Q3 | $327M | Buy |
2,675,326
+731,968
| +38% | +$95.4M | 0.2% | 101 |
|
|
2015
Q2 | $252M | Buy |
1,943,358
+479,583
| +33% | +$62.5M | 0.14% | 149 |
|
|
2015
Q1 | $197M | Buy |
1,463,775
+132,248
| +10% | +$17M | 0.11% | 189 |
|
|
2014
Q4 | $167M | Sell |
1,331,527
-1,039,805
| -44% | -$126M | 0.1% | 210 |
|
|
2014
Q3 | $289M | Sell |
2,371,332
-172,874
| -7% | -$21M | 0.17% | 140 |
|
|
2014
Q2 | $300M | Sell |
2,544,206
-1,006,526
| -28% | -$118M | 0.18% | 138 |
|
|
2014
Q1 | $427M | Sell |
3,550,732
-145,987
| -4% | -$17.4M | 0.26% | 98 |
|
|
2013
Q4 | $412M | Buy |
3,696,719
+686,095
| +23% | +$68.2M | 0.25% | 99 |
|
|
2013
Q3 | $277M | Sell |
3,010,624
-90,416
| -3% | -$8.18M | 0.18% | 133 |
|
|
2013
Q2 | $262M | Buy |
+3,101,040
| New | +$258M | 0.18% | 125 |
|
Other funds holding TMO
VCM
Ameriprise's TMO Position: Q1 2026 in Review
Ameriprise reduced its Thermo Fisher Scientific (TMO) stake by 0.86% in Q1 2026, selling an estimated $7.89M and leaving 1,670,400 shares worth $821M. The position accounts for 0.19% of the portfolio, ranked #117.
Ameriprise first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.53B in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Ameriprise held 1,670,400 shares of Thermo Fisher Scientific worth $821M as of Q1 2026.
- Ameriprise sold 14,545 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.89M.
- Thermo Fisher Scientific made up 0.19% of Ameriprise's portfolio in Q1 2026, its #117 holding.
- Ameriprise first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Thermo Fisher Scientific position peaked at $1.53B in Q3 2024.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.